Psychedelics and Investment
Kevin shares his journey into the world of psychedelics and mental health, highlighting his role in funding the Yale Center for Psychedelic Research. He discusses the inception of Transcend, a company focused on a unique compound currently in phase two trials, and the impressive fundraising success it has achieved. With a patent secured for their compound and a promising valuation, the future looks bright for this innovative venture.In this clip
From this podcast
My First Million
How This Billionaire Founder Finds +$20B Business Ideas (#495)
Related Questions